Development and in‐vitro evaluation of colon specific satranidazole tablet for the treatment of amoebiasis

Main Article Content

Jitendra Jagtap
Moreshwar Patil
Vijay Patil

Abstract

The delivery of drugs to the colon through oral route is valuable in treating diseases of the colon with the expectation to protect the drug during the transit time in the gastrointestinal tract and to allow its release only in the colon. The
objective of this study was to develop colon targeted drug delivery system for satranidazole that is used in the treatment of amoebiasis. Matrix tablets containing a combination of guar gum and hydroxypropyl methyl cellulose (HPMC) K4M in different ratios were prepared by wet granulation technique followed by enteric coating with Eudragit S100. Citric acid was also added, which might further facilitate drug dissolution and absorption. All formulations were evaluated for
hardness, swelling, drug content and inâ€vitro drug release studies. The results of the studies showed that colon targeted matrix tablet of satranidazole containing guar gum and HPMC K4M in the ratio proportion of 3:1 does not released drug
in 0.1N HCl (pH 1.2) and small intestine (phosphate buffer, pH 7.4). When the dissolution study was continued in colonic fluids (phosphate buffer, pH 6.8), the matrix tablets released 79.21% drug while in the presence of 4% rat cecal content,it was 94.08% at the end of the 24 h. It was expected that guar gum could be degraded by colonic microflora containing anaerobic microorganism and the release may be controlled by HPMC K4M and citric acid. Studies demonstrated that orally administered Satranidazole matrix tablets can be used effectively for the delivery of the drug to the colon.

Downloads

Download data is not yet available.

Article Details

How to Cite
Jagtap, J., Patil, M., & Patil, V. (2014). Development and in‐vitro evaluation of colon specific satranidazole tablet for the treatment of amoebiasis. Asian Journal of Pharmaceutics (AJP), 7(2). https://doi.org/10.22377/ajp.v7i2.26
Section
Articles

References

Sarasija S, Hota A. Colonâ€specific drug delivery systems. Indian J Pharm

Sci 2000;62:1â€8.

Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted

drug delivery systems. J Pharm Pharm Sci 2003;6:33â€66.

Ashford M, Fell J, Atwood D, Woodhead P. An inâ€vitro investigation into

suitability of pHâ€dependent polymers for colon targeting. Int J Pharm

;91:241â€5.

Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage forms

through the small intestine. Gut 1986;27:886â€92.

Van den MG, Kinget R. Oral colon specific delivery: A review. Drug Deliv

;2:81â€93.

Sinha VR, Kumria R. Binders for colon specific drug delivery: An in vitro

evaluation. Int J Pharm 2002;249:23â€31.

Krishniah YS, Satyanarayan S, Prasad RY, Rao NS. Evaluation of guar

gum as a compression coat for drug targeting to colon. Int J Pharm

;171:137â€46.

otts JE, Clendigs RA, Ackard WB, Wigisch WD. The biodegradability of

synthetic polymer. In: Guillet J, editor. Polymer science and technology.

Vol. 3. New York: Plenum Press; 1973. p. 61â€79.

Huang SI, Bansleben DA, Knox JR. Biodegradable polymers:

Chymotrypsin degradation of low molecular weight poly (esterurea)

containing phenylalanine. J Appl Polym Sci 1979;23:429â€37.

Jain SK, Jain A, Gupta Y, Ahirwar M. Design and development of hydrogel beads for targeted drug delivery to the colon. AAPS PharmSciTech 2007;8:E56.

Bansal K, Rawat MK, Jain A, Rajput A, Chaturvedi TP, Singh S.

Development of satranidazole mucoadhesive gel for the treatment of

periodontitis. AAPS PharmSciTech 2009;10:716â€23.

Aswar PB, Khadabadi SS, Kuchekar BS, Wane TP, Matake N. Development and inâ€vitro evaluation of colon specific formulation for orally

administered diclofenac Sodium. Arch Pharm Sci Res 2009;1:48â€53.

Tomlin J, Taylor JS, Read NW. The effects of mixed bacteria on a selection of viscous polysaccharides inâ€vitro. Nutr Rep Int 1989;39:121.

Baylis CE, Houtson AP. Degradation of guar gum by faecal bacteria.

Appl Environ Microbiol 1986;48:626.

Purushothaman M, Vijaya R. Formulation optimization and release

kinetics of tinidazole matrix, compression and spray coated tablets:

Effect of organic acid on colon targeted drug delivery systems. J Isr

Phys Ther Soc 2010;2:18â€32.

Sreenivas SA, Gadad AP. Formulation and evaluation of ondansetron

hydrochloride directly compressed mouth disintegrating tablets. Indian

Drugs 2006;43:35â€8.

Indian Pharmacopoeia. Vol. II. Ministry of Health and Family Welfare.

Government of India; 1996. p. 736.

Rajesh S, Vikas J. Simultaneous spectrophotometric estimation and

validation of ofloxacin and satranidazole in combined tablet dosage

form. J Appl Chem Res 2008;5:48â€56.

Prabhu P, Ahamed N, Matapady HN, Ahmed MG, Narayanacharyulu R,

Satyanarayana D, et al. Investigation and comparison of colon

specificity of novel polymer khaya gum with guar gum. Pak J Pharm

Sci 2010;23:259â€65.

Patel NV, Patel JK, Shah SH. Formlation and inâ€vitro evaluation of

mesalamine matrix tablets using chitosan for colonic drug delivery.

J Pharm Res 2009;2:1319â€23.

Nagaich U, Chaudhary V, Shubhini S, Bhattacharya S, Roy B, Tonpay SD.Formulation and evaluation of colon specific matrix tablet of

diethylcarbamazine citrate. J Pharm Res 2010;3:732â€6.